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Abstract—High circulating concentrations of homocysteine (ie, hyperhomocysteinemia [Hhcy]) impair the vascular 
function of peripheral conduit arteries and arterioles perfusing splanchnic and skeletal muscle regions. The effects of 
HHcy on coronary resistance vessel function and other indexes of vascular function, ie, arterial permeability and 
stiffening, are unclear. We tested the hypotheses that HHcy impairs coronary resistance vessel reactivity; increases 
carotid arterial permeability; and initiates arterial stiffening. Male rats that consumed folate-replete (CON, n=44) or 
folate-deplete (HHcy, n=48) chow for 4 to 5 weeks had total plasma homocysteine concentrations of 7±2  or 58 ±4  
/xmol/L, respectively. Maximal acetylcholine-evoked relaxation («*40% vs ^60%) and tension development from 
baseline in response to nitric oxide synthase inhibition («*20% vs «*40%) were lower (both P < 0.05) in coronary 
resistance vessels («*120 /xm, internal diameter) isolated from HHcy versus CON animals, respectively, whereas sodium 
nitroprusside-evoked relaxation and contractile responses to serotonin and potassium chloride were similar between 
groups. Permeability to 4400 MW and 65 000 MW fluorescently labeled (TRITC) dextran reference macromolecules 
(quantitative fluorescence microscopy) was ^44% and «*24% greater (P <0.05), respectively, in carotid arteries from 
HHcy versus CON rats. Maximal strain, evaluated by using a vessel elastigraph, was less («*32% vs 42%, P < 0.05) in 
carotid arterial segments from HHcy versus CON animals, respectively. Finally, estimates of oxidative (copper- 
zinc+ manganese superoxide dismutase activity) and glycoxidative (pentosidine) stress were elevated (P <0.05) in 
arterial tissue from HHcy versus CON rats. These findings suggest that moderately severe HHcy evoked by 
folate-depletion impairs endothelium-dependent relaxation of coronary resistance vessels, increases carotid arterial 
permeability, and initiates arterial stiffening. HHcy may produce these effects by a mechanism associated with increased 
oxidative and glycoxidative stress. (Arterioscler Thromb Vasc Biol. 2002;22:772-780.)
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E xperimentally confirmed risk factors for cardiovascular 
disease do not fully account for its widespread preva- 
lence.1 For example, classic risks including family history, 
hypercholesterolemia, male sex, physical inactivity, obesity, 
and smoking are responsible for only 50% to 70% of the 
actual risk for cardiovascular disease.2 Therefore, other vari­
ables have com e under scrutiny for the ir potential 
contribution.
Methionine is an essential amino acid that is released 
during protein digestion. As methionine is metabolized, the 
sulfhydryl-containing amino acid homocysteine (Hcy) is 
formed. Evidence is accumulating that high levels of plasma 
Hcy are a risk factor for cardiovascular disease.2 Hyperho- 
mocysteinemia (HHcy) can result from genetic deficiencies 
of enzymes required for Hcy metabolism or from nutritional 
deficits of the vitamins that serve as cosubstrates or cofactors 
for these enzymes.
HHcy could initiate and/or contribute to cardiovascular 
risk by impairing vascular function.3 Three indices of arterial 
function that are compromised to varying degrees in individ­
uals with cardiovascular disease are vascular reactivity,4 
perm eability,5 and stiffness.6 W ith specific regard to 
resistance-sized arteries, HHcy impairs function of vessels 
perfusing human forearm,7 8 rat skeletal muscle,910 and mu­
rine mesentery.11 No studies have examined the effects of 
HHcy on coronary resistance vessels. This circulation is 
important because it is the primary regulator of myocardial 
blood flow.12 Further, the potential for HHcy to influence 
arterial permeability has never been investigated, and the 
effects of HHcy on arterial stiffness are inconclusive.13-15 
Evaluating these latter two indices of vascular function is 
relevant clinically because increased permeability could fa­
cilitate lipoprotein accumulation in the arterial wall and thus 
contribute to lesion development and/or severity.5 Greater
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arterial stiffness may compromise vasomotor capacity and 
necessitate increased myocardial oxygen demand.16
In the present study, we tested the hypotheses that HHcy 
evoked by folate-depletion 1) impairs coronary resistance 
vessel reactivity, 2) increases carotid arterial permeability, 
and 3) promotes arterial stiffening. In addition, tissue markers 
of oxidative and glycoxidative stress were measured to 
determine their potential association with HHcy-induced 
vascular dysfunction.
M ethods 
Experimental Animals and Diets
All protocols used in this study were approved by the Animal Use 
and Care Committee at the University of California, Davis, and 
conformed to guidelines set by the American Physiological Society 
and Animal W elfare Act. Male Sprague-Dawley rats (50 to 75 g) 
were housed individually under controlled temperature (23°C) and 
light conditions (12:12-hour light:dark cycle) and were allowed 
standard rodent chow and water ad libitum for 1  week after arrival 
from the breeder. Animals then were divided such that one group 
received an amino acid defined diet containing 8 g o f folate per kg 
of chow (control animals [CON], n= 44), while the other consumed 
a folate-deplete diet (HHcy, n= 48). Because folate is required to 
metabolize Hcy to methionine via remethylation, plasma Hcy is 
elevated in animals that are deficient in folate.17 An antibiotic 
(succinylsulfathiazole, 1%) was added to both diets to eradicate 
intestinal microflora that are capable of synthesizing folate endoge­
nously. Chow consumed by animals in the CON (diet #517814) and 
HHcy (diet #517777) groups was obtained from Dyets Inc.
General Procedures
After consuming the appropriate diet for 4 to 5 weeks, rats were 
anesthetized with ketamine (30 to 50 mg/kg, intramuscularly) and 
xylazine (3 to 5 mg/kg, intramuscularly). The caudal artery then was 
cannulated to measure arterial pressure and obtain blood samples for 
later quantification of Hcy and indices o f oxidant stress (see Plasma 
and Tissue Analyses). Both carotid arteries then were isolated and 
dissected free o f surrounding tissue. The right carotid artery was 
ligated at both ends and cannulated proximally and distally by using 
a 21-gauge blunt needle. This segment was transferred to a micro­
scope viewing chamber to assess vascular permeability. Segments of 
the contralateral carotid artery were excised, frozen in liquid nitro­
gen, and stored at 80°C for later measurement o f vascular 
stiffening and indices of oxidative/glycoxidative stress or placed in 
ice-cold, oxygenated, normal physiological salt solution (NPSS; pH 
^7 .4 0 ) for vascular reactivity experiments. Next, the heart was 
excised and placed in ice-cold NPSS, and coronary resistance vessels 
were isolated and used to assess vascular function. Finally, a section 
of liver and the remaining arterial tree (ie, ascending and descending 
aorta, right and left iliac and femoral arteries) were immersed in 
liquid nitrogen and stored at 80°C for later analysis of oxidative or 
glycoxidative stress. An additional section of liver was obtained and 
frozen in liquid nitrogen to determine folate concentrations.
Carotid Arterial Permeability
W e tested the hypothesis that permeability is greater in carotid 
arteries from HHcy compared with CON rats. With quantitative 
fluorescence microscopy, three 10-minute perfusion phases were 
performed on each vessel. In the initial phase, the artery was 
perfused (7 mL/min, 100 mm Hg, 37°C, pH ^7 .4 ) with clear, 
non-fluorescent buffer (Krebs-Henseleit solution 1% bovine serum 
albumin) to measure baseline fluorescence intensity. Second, either 
4400 MW  dextran molecules (estimated Stokes diameter, 1.4 nm; 42 
g/mL in perfusate) or 65 000 MW dextran molecules (estimated 
Stokes diameter, 5.7 nm; 42 jxg/mL in perfusate) labeled with 
tetramethylrhodamine isothiocyanate (TRITC; excitation maxi- 
m um =494 nm, emission m axim um =518 nm) were perfused through 
the arterial lumen and viewed/recorded through an inverted light
microscope. Dextran was used as the reference molecule, because 
this non-lipid particle does not bind specifically to the artery 
wall.18-21 During this second perfusion phase, there is a rapid 
increase in intraluminal fluorescence intensity as TRITC-labeled 
dextran fills the artery lumen. During the third phase, the artery was 
perfused again with non-fluorescent buffer that washes the TRITC- 
labeled dextran out o f the lumen. The washout phase is analyzed as 
two distinct processes. The first, rapid washout represents dextran 
exiting the vessel lumen, whereas the second, slower washout 
represents dextran exiting the vessel wall. Arterial permeability is 
estimated by the amount o f TRITC-labeled dextran that accumulates 
in the arterial wall (If accumulation). Calculating If accumulation 
involves finding the intersection o f tangents drawn to approximate 
the rapid and slow washout phases. To determine accumulation rate, 
If accumulation is divided by time of perfusion (ie, 10 minutes). 
Fluorescence values then are converted from millivolts/min to ng ■ 
c m 2 ■ min^1 by knowing the 1) surface area and 2) lumen volume of 
the vessel in the photometric window, 3) fluorescence intensity at 
time 0 (Ig,), which occurs at the beginning of dye perfusion, and 4) 
concentration o f dextran in the perfusate. IF accumulation rates were 
performed in triplicate for each vessel, and the values were 
averaged.18-21
Carotid Arterial Elasticity
W e tested the hypothesis that vascular distensibility is less in carotid 
arteries from HHcy versus CON rats. Two stainless steel rods 
(200- m outside diameter) were inserted through the lumen of a 
1-mm section o f carotid artery in a parallel manner while the vessel 
was immersed in Krebs-Henseleit buffer. One rod was attached to a 
force transducer, while the other was attached to a motorized 
controller. This modified vessel myograph, termed an elastigraph, 
allowed the vessel to be stretched in a radial manner at a constant rate 
until breakage, while vessel tension was recorded via a force 
transducer. In preparation for each stretch, carotid arterial segments 
were preconditioned three times at ^1 0 %  of their maximal load. By 
using these methods, stress (vessel tension development divided by 
vessel area) versus strain curves were generated so that maximum 
strain (ie, strain at vessel breakage), maximal stress (vessel tension at 
maximum strain), and failure energy (area under the stress-strain 
curve) could be calculated.1622 Experiments were performed with 
three 1-mm segments o f each carotid artery, and the results were 
averaged.
Coronary and Carotid Arterial Reactivity
These studies tested the hypothesis that reactivity of coronary 
microvessels and carotid arteries is impaired in HHcy compared with 
CON rats. After placing the heart in ice-cold NPSS, the left coronary 
artery was traced toward the apex with the aid o f a dissecting 
microscope (Leica Stereo Zoom 5). Third-order branches o f this 
artery were isolated, removed, and mounted on a wire-type myo­
graph using methods we have described.23 24 After a 30-minute 
equilibration period, a series of internal circumference-active ten­
sion curves was constructed to determine the vessel diameter that 
evoked the greatest tension development (Lm^  to 100 mmol/L 
KCl.23 24 Lmax was determined for every vessel, and this optimal 
resting tension was maintained throughout the study.
After a 30-minute equilibration period, five experimental proto­
cols were performed, each separated by 20 to 30 minutes during 
which the vessel bathing medium was exchanged with NPSS several 
times. In order, concentration response curves to: 1) a non-receptor 
mediated vasoconstrictor (KCl; 15 to 100 mmol/L); 2) an endothe­
lium-dependent vasodilator (acetylcholine; 10^8 to 10^4 mol/L); 3) a 
receptor mediated vasoconstrictor (5-hydroxytryptamine hydrochlo­
ride, serotonin; 10^9 to 10^5 mol/L); 4) a single dose (10^6 mol/L) of 
^-m onom ethyl-L-arginine (L-NMMA; an inhibitor o f nitric oxide 
synthase); and 5) an endothelium-independent vasodilator (sodium 
nitroprusside; 10^9 to 10^5 mol/L) were performed on each vessel. 
Relaxations to acetylcholine and sodium nitroprusside and constric­
tions in response to L-NMMA were evaluated from stable tension 
development in response to 45 mmol/L KCl. Contractile responses 
are presented as milligrams of tension development, while relaxation
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responses are presented as a percentage of KCl-induced precontrac­
tion. All five protocols were performed on coronary resistance 
arteries, whereas only acetylcholine- and sodium nitroprusside- 
evoked relaxation were evaluated by using carotid arteries. Samples 
from all buffers and each tissue bath were analyzed frequently for 
Po2, Pco2, and pH. Tension data were recorded and processed 
continuously by a computer through an analog-to-digital interface 
card (Biopac Systems Inc) that allowed for subsequent off-line 
quantitative analyses.23 24
NPSS contained (in mmol/L) NaCl 125, KCl 4.7, KH2PO4 1.2, 
MgSO4 1.2, CaCl2 2.5, NaHCO3 18, Na2EDTA 0.026, and glucose 
11.2. Acetylcholine, sodium nitroprusside, L-NMMA (Sigma Chem­
ical), and serotonin (Peninsula Laboratories) were purchased com­
mercially and prepared daily from stock solutions with distilled 
deionized water.
Plasma and Tissue Analyses
Blood from the caudal artery was collected into prechilled tubes 
containing EDTA, centrifuged at 2500g for 10 minutes at 4°C, stored 
at 80°C, and used to quantify total plasma Hcy (tHcy). tHcy refers 
to the totality o f Hcy present after the quantitative reductive cleavage 
of all disulfide bonds.25 Briefly, tHcy was analyzed by using 
high-performance liquid chromatography with fluorescence detec- 
tion.26 This assay quantifies the combination of free reduced homo­
cysteine (= 1%  of total), mixed disulfides (= 2 0  to 30% of total), and 
protein-bound homocysteine ( 70 to 80% of total).
Arterial tissue was combined from 4 animals from the same 
group and analyzed for 1) copper-zinc manganese superoxide 
dismutase activity (C u-Zn+M n SOD), an estimate o f oxidative 
stress (kinetic spectrophotometric enzyme assay)27; 2) collagen- 
associated fluorescence, a general marker o f glycoxidative stress 
(scanning fluorescence spectroscopy)28; and 3) pentosidine, a more 
specific marker o f glycoxidative stress (high-performance liquid 
chromatography).22-29-30
Sections o f liver were obtained to measure thiobarbituric acid 
reactive substances (TBARS), an estimate o f lipid oxidation, by 
using fluorescence detection.31 Procedures implemented to increase 
the accuracy of this assay included 1) performing the assay on fresh 
tissue on the day of collection; 2) adding butylated hydroxytoluene 
to the tissue homogenate to limit TBARS generation during the 
assay; and 3) using only malondialdehyde that was within the 
spectrophotometric guidelines. Liver sections also were used to 
quantify folate with a conventional microbiological assay.32 Tissue 
protein was determined by using a Bradford reagent (Biorad), and 
arterial collagen (hydroxyproline) was measured by colorimetric 
analysis o f sample hydrosylates.30 33
Statistical Analyses
Animal and vessel characteristics, indices o f arterial permeability 
and compliance, and all plasma and tissue markers were compared 
between groups by using an unpaired t test.34 Vascular relaxation and 
constriction responses were compared by using a two-way (dose 
versus experimental group) repeated-measures ANOVA. Planned 
comparisons were made at each drug dose to determine whether 
differences existed between groups. All values are presented as 
m eans±SE. Statistical significance was accepted when P < 0.05.
Results  
Animal Characteristics
HHcy rats had higher plasma Hcy concentrations (58±4 vs 7 ± 2  
jumol/L) and lower liver folate (0.97±0.10 vs 12.10±0.20 jug 
folate/g liver) and body weight (285 ± 5  vs 333 ±  10 g) than CON 
animals, respectively. Age (63 2 and 61 1 days), mean arterial 
blood pressure (74 15 and 82 8 mm Hg), and plasma cysteine 
concentrations (165 4 and 157 4 mol/L) were similar in 
HHcy and CON rats, respectively. All animals appeared healthy 
and robust at the time of study.
Figure 1. Accumulation of 4400 MW (A) and 65 000 MW (B) 
dextran reference macromolecules was greater (*P<0.05) in 
carotid arteries from HHcy compared with CON rats. Values are 
mean±SE.
Carotid Arterial Permeability
Accumulation of non-lipid reference molecules within the 
arterial wall was quantified by using fluorescence microscopy 
to test the hypothesis that permeability is greater in vessels 
from HHcy versus CON rats. Compared with vessels from 
CON rats, those from HHcy animals showed greater accu­
mulation (ng • min-1 cm2) of 4400 MW («*44% greater) and 
65 000 MW  TRITC-labeled dextran molecules («*24% 
greater; Figure 1).
Carotid Arterial Elasticity
Stress versus strain curves were generated with an elastigraph 
to determine whether carotid arteries from HHcy rats are 
stiffer or less distensible than those from CON animals. We 
observed a 25% decrease in maximal strain from carotids of 
HHcy compared with CON rats (Figure 2). Data also indi­
cated a trend (P = 0.106) toward decreased failure energy 
(total area under stress versus strain curve) in vessels from 
HHcy (25.9±3.0 mN) versus CON (36.4±5.7 mN) rats. 
Maximal stress (mN/mm2) was similar in vessels from HHcy 
(132± 13) versus CON (154±10) animals.
Coronary Microvascular and Carotid 
Arterial Reactivity
Wire-type myographs were used to test the hypotheses that 
coronary and carotid arterial reactivity are impaired in HHcy 
versus CON animals. Vessel characteristics were similar 
between groups for both the coronary and carotid arteries 
(Table). Acetylcholine produced a dose-dependent relaxation 
that was impaired in coronary and carotid arteries from HHcy 
versus CON animals. Relaxation in response to sodium 
nitroprusside was similar between groups in both vascular 
segments. These data suggest that endothelium-dependent
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Figure 2. A, Stress versus strain curve of a carotid artery from a 
CON and HHcy rat. Note that vessel breakage occurs at a lower 
stress and strain in the HHcy compared with CON vessel. The 
area under each curve, until the break point, is the failure 
energy. Group mean data shown in B indicate lower (*P<0.05) 
maximal strain in vessels from HHcy compared with CON ani­
mals. Values are mean±SE.
function was impaired and endothelium-independent function 
was unaltered in coronary (Figure 3A and 3B) and carotid 
arteries (Figure 4) from HHcy versus CON animals. In 
coronary resistance vessels, L-NMM A-induced tension de­
velopment (percentage increase from baseline precontraction) 
was greater in CON (44±9% ) versus HHcy (23 ±7% ) rats, 
even though baseline precontractions were similar between
groups (ie, 162±27 and 163±29 mg, respectively). These 
findings provide an estimate of basal nitric oxide production35 
and suggest that it is lower in vessels from HHcy relative to 
CON animals. Receptor- and non-receptor-mediated contrac­
tile responses were similar between groups. Specifically, 
absolute tension development in response to serotonin and 
KCl concentration-response curves was not different in 
coronary resistance vessels from rats that consumed folate- 
replete or folate-deplete chow.(Figure 3C and 3D) Results 
were similar when tension development was normalized for 
vessel length or tension developed at LMAX (data not shown).
Indexes of Glycoxidative and Oxidative Stress
Initially, we quantified collagen-associated fluorescence 
(CAF), a nonspecific indicator of glycoxidative stress that is 
thought to result from non-enzymatic glycation. Contrary to 
our hypothesis, we consistently observed reduced CAF in 
vessels from HHcy relative to CON rats. Because CAF 
represents the total amount of fluorescence in vascular 
collagen digests, we next quantified pentosidine, a highly 
specific marker of glycoxidative stress,22-29-30 using the same 
tissue hydrosylates. We observed an ^60-fo ld  increase in 
pentosidine (pmol pentosidine//xg hydroxyproline) in vessels 
from HHcy (0.932±0.250) versus CON (0.016±0.01) rats, 
supporting our hypothesis that HHcy evokes glycoxidative 
stress. Liver TBARS (0.266±0.117 vs 0.152±0.035 nmol 
malondialdehyde/mg protein) and arterial tissue Cu-Zn+M n 
SOD activity (146±9 vs 108±3 mol • min_1 • mg-1 protein) 
also were greater in HHcy versus CON animals, respectively. 
Hydroxyproline ( g/cm2 of carotid artery) was similar in 
arterial tissue from CON (140± 10) and HHcy rats (135± 14).
D iscussion
We tested the hypothesis that arterial function is impaired in rats 
that were made hyperhomocysteinemic by consuming a folate- 
deplete diet. Our findings indicate that HHcy 1) impairs
Characteristics of Carotid Arteries and Coronary Resistance Vessels
CON HHcy
Coronary resistance arteries
Internal diameter, baseline, ptm 128 ±13 111 ±4
Internal diameter, Lm®, ptni 277 ±14 250±12
%lncrease in internal diameter, baseline to 124 ±12 128±12
Tension developed at U*x, nig 217 ±9 182±6
%Precontraction for acetylcholine dose-response 84±2 87±4
%Precontraction for sodium nitroprusside dose-response 96±8 93 ±7
%Precontraction before adding 75 ±6 75±8
A/G-monomethyl-L-arginine 
Carotid arteries
Internal diameter, baseline, ptm 541 ±16 544 ±20
Internal diameter, Lm®, ptni 848 ±20 787±19
%lncrease in internal diameter, baseline to 59±5 47±6
Tension developed at U*x, nig 530±30 540 ±40
%Precontraction for acetylcholine dose-response 87 ±4 93 ±3
%Precontraction for sodium nitroprusside dose-response 86±5 88±10
Values are mean±SEM.
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Figure 3. Vascular reactivity experiments show that acetylcholine-evoked relaxation was less (*P<0.05, A) in coronary resistance arter­
ies from HHcy compared with CON rats, while sodium nitroprusside-evoked relaxation (B) was similar between groups. Tension devel­
opment in response to potassium chloride (C) and serotonin (D) was similar between groups. Values are mean±SE.
acetylcholine-evoked relaxation in coronary resistance vessels 
and carotid arteries, 2) increases estimates of vascular perme­
ability in carotid arteries, and 3) decreases maximal arterial 
distensibility in carotid arteries. Further, estimates of oxidative 
(Cu-Zn Mn SOD) and glycoxidative (pentosidine) stress were
Figure 4. Vascular reactivity experiments show that 
acetylcholine-evoked relaxation was less (*P<0.05, A) in carotid 
arteries from HHcy compared with CON rats, while sodium 
nitroprusside-evoked relaxation (B) was similar between groups. 
Values are mean±SE.
elevated in arterial tissue from HHcy versus CON animals. 
Collectively, these findings support the hypothesis that vascular 
function is impaired by moderately severe HHcy and may be 
associated with increased oxidative and glycoxidative stress. 
While these data confirm previous reports regarding the influ­
ence of HHcy on conduit artery (ie, aorta, femoral, carotid, and 
brachial artery) function,1136-41 new information is presented 
concerning coronary microvascular reactivity and permeability 
and stiffness of conduit arteries.
Reactivity of Coronary Resistance Arteries
Our study is the first to investigate the influence of moder­
ately severe HHcy on isolated coronary resistance vessel 
reactivity. This circulation is important, because these arteries 
provide the primary resistance to myocardial blood flow.12 
Moreover, because a heterogeneity exists among vessels of 
various sizes and from different vascular beds regarding 
reactivity to similar agents,12,42 the effects of HHcy cannot 
necessarily be extrapolated from one region to another. For 
instance, HHcy (tHcy ^ 9  vs 4 ju.mol/L) impaired endotheli­
um-dependent dilation of murine mesenteric arterioles to a 
much greater extent than aortic rings, even though vessels 
were obtained from the same animals.11 Therefore, results 
from studies examining the effects of HHcy on large conduc­
tance arteries cannot be extrapolated to small resistance 
vessels.
We observed that acetylcholine-evoked relaxation is im­
paired, whereas sodium nitroprusside-evoked relaxation is 
unchanged, in coronary resistance vessels from HHcy versus 
CON rats (tHcy 58 vs 7 mol/L, respectively). These 
findings suggest that endothelium-dependent relaxation is 
compromised, whereas nitric oxide/cGMP-dependent intra­
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cellular signaling pathways within vascular smooth muscle 
are unchanged by HHcy produced by folate depletion. Our 
results may have been different had another endothelium- 
dependent agent and/or precontractor substance been used. 
For example, the potential contribution to vasorelaxation 
from endothelium-derived hyperpolarizing factor (EDHF) 
cannot be evaluated in vessels that have been precontracted 
by using KCl. In this regard, EDHF has been shown to 
contribute to acetylcholine-evoked relaxation in canine cor­
onary microvessels43 and rat mesenteric arteries.44 W e tried 
several alternate endothelium-dependent vasorelaxing sub­
stances and precontracting agents in preliminary studies23,24 
but there was a lack of reproducibility and unstable tension 
development, respectively, rendering them unacceptable. In 
any case, we refer to our assessment of endothelial function 
as acetylcholine-evoked vasorelaxation and believe that nitric 
oxide release evoked by muscarinic receptor stimulation is 
largely responsible for the observed vasorelaxation. Evidence 
supporting this is that acetylcholine-evoked relaxation in 
KCl-precontracted rat coronary microvessels is abolished by 
atropine (10~6 mol/L) or L-NMMA (10~6 mol/L).23 Never­
theless, because coronary microvessels and carotid arteries 
(see below) were precontracted with KCl, any role that EDHF 
may have in acetylcholine-evoked relaxation in rats with 
HHcy cannot be determined in the present study.
In addition to stimulated (ie, acetylcholine-evoked) release 
of nitric oxide being blunted by HHcy, we observed 50% 
less L-NM M A-evoked constriction (ie, an estimate of basal 
nitric oxide release)35 in coronary resistance vessels from 
these animals compared with CON rats. Although we believe 
that the generated tension was in response to L-NM M A- 
induced inhibition of endothelial cell nitric oxide synthase, 
other sources of this enzyme may have been blocked. For 
instance, recent findings indicate that nitric oxide synthase is 
present in vascular smooth muscle of bovine carotid arteries 
and can effect physiological contractile responses.45 Another 
consideration is that functional estimates of basal nitric oxide 
production in the present study are specific to vessels pre­
contracted with KCl. Therefore, results may have been 
different had another L-arginine analogue and/or preconstric­
tor agent been used.
We also assessed tension development of coronary mi­
crovessels in response to receptor-mediated (ie, serotonin) 
and non-receptor mediated (ie, KCl) contractile agents. Sero­
tonin was chosen for study because it is an important 
regulator of vascular tone and is released in significant 
quantities when platelets aggregate in response to a local 
thrombotic event.46 KCl-induced tension development was 
assessed because it occurs via activation of voltage-gated 
calcium channels and thus represents a contractile mechanism 
that is receptor-independent. Contractile responses to these 
two agents were similar between groups. Therefore, it ap­
pears that reduced stimulated (ie, acetylcholine-evoked) and 
basal (ie, L-NMMA-evoked) nitric oxide production ob­
served in vessels from HHcy animals was not severe enough 
to result in exaggerated contractile responses to serotonin 
and KCl.
Reactivity, Permeability, and Stiffness of 
Conduit Arteries
Impaired endothelial function of conduit arteries has been 
demonstrated in animal and human models of HHcy. For 
example, endothelium-dependent relaxation was compro­
mised in aortic rings from CBS / mice fed standard (tHcy 
«*9 jumol/L),11 methionine-enriched (tHcy «*24 pimol/L),41 or 
folate-reduced chow (tHcy 25 mol/L),39 and carotid arter­
ies from monkeys that consumed methionine-enriched/folic 
acid-reduced chow (tHcy «*11 ju.mol/L).36 The tHcy control 
values from these studies were 4, 6, 6, and 4 mol/L, 
respectively. Further, flow-mediated dilation was blunted in 
femoral arteries from monkeys,36 brachial and femoral arter­
ies from patients with homocystinuria (tHcy 63 vs 13
mol/L),38 and the brachial artery of healthy individuals after 
ingesting methionine (tHcy 25 vs 10 mol/L) or homocys­
teine (tHcy «*53 vs 10 pimol/L) orally.40 Our results confirm 
and extend these findings to include isolated carotid arteries 
from rats with moderately severe HHcy evoked by folate 
depletion (tHcy «*58 vs 7 ju.mol/L).
We also determined whether arterial permeability is in­
creased in carotid arteries from HHcy compared with CON 
rats. Strong rationale exists for posing this question. First, 
HHcy has been shown to exert oxidant stress,47 a finding that 
was confirmed in the present study by our observations that 
liver TBARS and arterial tissue Cu-Zn Mn SOD and pen- 
tosidine were greater in HHcy than in CON animals. Second, 
we have reported that arterial permeability is increased by 
oxidant stress, and these changes are attenuated by several 
anti-oxidants.19 Finally, HHcy has been shown by some 
laboratories to increase atherosclerotic lesion progres- 
sion.48-51 To address whether HHcy evokes oxidant stress to 
an extent whereby arterial permeability is increased, real-time 
measurements of dextran accumulation were made by using 
methods whereby flow rate, hydrostatic pressure, pH, tem­
perature, and superfusate and perfusate compositions were 
controlled to simulate physiological conditions. We observed 
that this estimate of arterial permeability, ie, the accumulation 
rate of 4400 and 65 000 MW dextran reference molecules, 
was greater in arteries obtained from HHcy compared with 
CON animals, thus supporting our hypothesis. These data, 
taken together with findings that HHcy initiates a cascade of 
inflammatory mediators,48,52 may partly explain why some 
investigators have shown that atherosclerotic lesion develop­
ment is enhanced by HHcy.
Another index of vascular function ie, arterial stiffness, 
was estimated in carotid arteries from HHcy and CON rats. 
Increased arterial stiffness is observed in patients with ath­
erosclerosis, diabetes, and hypertension.53 Further, vascular 
stiffening may be a cause or consequence of impaired 
reactivity and is associated with increased arterial permeabil­
ity. A consensus regarding the influence of HHcy on esti­
mates of vascular stiffness is lacking. In this regard, HHcy 
has been shown to correlate strongly,13 marginally,15 or not at 
all14 with arterial stiffness in experiments that used a variety 
of methods to evaluate stiffness and evoke increases in Hcy. 
In the present study, vascular stiffening was estimated by 
quantifying the passive elastic properties of carotid arteries 
by using an elastigraph. We observed lower maximal strain in
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carotid arteries from HHcy versus CON animals, indicating 
that HHcy causes vessels to become less maximally disten- 
sible.54 Additionally, there was a trend toward decreased 
failure energy in carotid arteries from HHcy rats, suggesting 
that carotid arteries have reduced “elastic” capacity.55 More 
severe biomechanical alterations may have occurred had the 
duration of HHcy been extended beyond 4 weeks.
Increased arterial stiffening and/or vascular permeability 
may be caused by the accumulation of advanced glycation 
end-products (AGEs) that occurs during non-enzymatic gly- 
cation within the vascular wall.22 In the present study, we 
sought to determine whether HHcy causes an increase in 
glycoxidation, thus resulting in the accumulation of AGEs. 
This is particularly important with regard to HHcy-induced 
vascular dysfunction, because increased expression of an 
AGE receptor recently was reported in mice with HHcy.48 We 
observed a dramatic increase in pentosidine, a standard and 
specific in vivo biomarker of glycoxidative damage,22,29,30 in 
arterial tissue from HHcy relative to CON animals. These 
data, taken together with our findings that estimates of 
oxidative stress (eg, liver TBARS and arterial Cu-Zn Mn 
SOD) are elevated in rats with HHcy evoked by folate 
depletion, suggest that vascular dysfunction is due, at least in 
part, to increased oxidative and glycoxidative stress.
Concern regarding our interpretation of oxidant stress may 
be raised. Specifically, elevated Cu-Zn+M n SOD activity 
could reflect increased oxidant stress and/or increased anti­
oxidant capacity. We believe that Cu-Zn+M n SOD activity 
was greater in arterial tissue from HHcy versus CON rats in 
response to oxidant stress evoked by HHcy. In this regard, 
exposure of animals to high-oxygen environments or to 
compounds that increase intracellular superoxide anion gen­
eration (eg, methylene blue) results in increased SOD activ- 
ity.56 Further, the genetic response to superoxide in bacteria 
includes an induction of SOD.57 This information, taken 
together with findings that superoxide anion production is 
greater in aorta from CBS-deficient mice,11 lead us to believe 
that elevated arterial C u-Zn+M n SOD was functioning as an 
antioxidant defense mechanism to correct/compensate for an 
imbalance in the redox state (eg, increased superoxide anion) 
created by HHcy. Although this explanation is feasible, it 
cannot be made with certainty because we did not measure 
superoxide anion production directly.
Past studies have produced HHcy by 1) acute Hcy 
ingestion; 2) acute and chronic methionine ingestion; 3) 
heterozygous deletion of the gene encoding CBS in mice 
(ie, C B S + /—); 4) folate-restriction/depletion; and 5) com­
binations of 2, 3, and/or 4. W e elevated Hcy concentrations 
to a moderately severe (58 4 uM) and pathophysiologi­
cally relevant degree58 59 by feeding rats folate-deficient 
chow for 4 to 5 weeks. Because folate is required by the 
two main pathways responsible for Hcy metabolism, ie, the 
rem ethylation pathway and the transulfuration pathway, 
plasm a Hcy concentrations increase in rats that consume 
folate-deficient chow .17 Although this m ethod is extremely 
reproducible and reliable, it does have limitations. For 
example, some studies,60-63 but not all,48 64 indicate that 
low folate levels contribute to cardiovascular disease in a 
manner that is independent o f the ability of low folate to
elevate Hcy. Interestingly, endothelial dysfunction of aor­
tic rings was observed in CBS / mice rendered hyper- 
homocysteinemic via methionine supplementation com­
pared with those that consumed standard chow, even 
though both groups possessed normal liver folate concen- 
trations.41 W hereas these results suggest that vascular 
reactivity is compromised by HHcy per se rather than by 
its com bination with folate depletion, it should be noted 
that CBS / mice fed a folate-deficient diet developed 
aortic vascular dysfunction more quickly than CBS / 
mice supplemented with methionine. Further, folate defi­
ciency has been shown to directly impair endothelial nitric 
oxide production8 and may have contributed to vascular 
dysfunction observed in the present study. Because of this, 
caution should be used when extrapolating our findings 
beyond the experim ental setting of moderately severe 
HHcy evoked by folate depletion.
In summary, we observed that moderately severe HHcy 
produced by folate depletion 1) impairs endothelium- 
dependent relaxation of coronary microvessels and carotid 
arteries, 2) increases carotid arterial permeability to reference 
macromolecules, 3) decreases maximal carotid arterial dis- 
tensibility, and 4) elevates indices of oxidative and glyc- 
oxidative stress. These findings provide new information 
regarding the multiple methods whereby HHcy may contrib­
ute to cardiovascular disease.
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